News

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and exits the cell. Until recently, scientists believed antibodies couldn't ...
This two-step process is designed to guide the immune response further along the path toward bnAb development by generating VRC01-class antibodies -- early immune defenses with key features of bnAbs.
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.
Bio, Inc. has announced a licensing agreement with AstralBio Inc. for a first-in-class antibody designed to target Activin E, a key factor in regulating energy balance and fat distribution.
IBIO), an AI-driven innovator of precision antibody therapies, today announced new promising preclinical data for its first-in-class Activin E antibody unveiled in January. Data from the recently ...
Its ability to measure neutralising antibodies can help determine the efficacy of new vaccines. Read more at straitstimes.com ...
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Bio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced a licensing agreement with AstralBio Inc. for a ...
Dr Ivo Tews, a Professor in Structural Biology at Southampton, added: “We used a supercomputer to visualise the structure of the antibody in atomic detail, allowing us to position extra ...
Calcitonin gene-related peptide (CGRP) monoclonal antibodies, or CGRP antagonists, were the first class of migraine preventive medications that were explicitly developed to preventively treat ...